InterVenn Biosciences
Updated: February 21, 2026
Aldo Carrascoso - Co-Founder and CEO
Country: USA | Funding: $244.4M (+)
Founded: 2017
Website: https://intervenn.bio/
InterVenn Biosciences is a liquid biopsy company pioneering the development of clinically useful glycoproteomic diagnostics. It has combined the molecular resolution of mass spectrometry with the power of artificial intelligence to create a unique platform for discovering new biomarkers, providing more effective treatments, developing precision medicine clinical trials, and identifying new targets. The company has also developed GlcyoKnow Ovarian, a laboratory test for assessing the risk of malignancy in confirmed pelvic lesions prior to planned surgery. It complements imaging data and clinical assessment, facilitating more informed and personalized treatment decisions.
Founded: 2017
Website: https://intervenn.bio/
InterVenn Biosciences is a liquid biopsy company pioneering the development of clinically useful glycoproteomic diagnostics. It has combined the molecular resolution of mass spectrometry with the power of artificial intelligence to create a unique platform for discovering new biomarkers, providing more effective treatments, developing precision medicine clinical trials, and identifying new targets. The company has also developed GlcyoKnow Ovarian, a laboratory test for assessing the risk of malignancy in confirmed pelvic lesions prior to planned surgery. It complements imaging data and clinical assessment, facilitating more informed and personalized treatment decisions.
